References
- MacDonald JS, Schein PS, Woolley PV, et al. 5Fluorouracil, Adriamycin and mitomycin C (FAM): A new combination chemotherapy program for advanced gastric carcinoma. Ann Intern Med 1980; 93: 533–536
- Treat J, Falchuk S, Woolley P, et al. Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center Experience. Am J Clin Oncol 1989; 12(2)162–168
- Preusser P, Wilke H, Acterrath W, et al. Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 1989; 7: 1310–1317
- Drewinko B, Yank LY. Cellular basis for the inefficacy of 5 FU in human colon carcinoma. Cancer Treat Rep 1985; 69: 1391–1398
- Leichman L, McDonald B, Dindogru A, et al. Cisplatin: An active drug in the treatment of disseminated gastric cancer. Cancer 1984; 53: 1822
- Schabel FM, Jr, Trader MW, Laster WR, Jr, et al. Cisdichloro diamineplatinum II: combination chemotherapy and cross resistance studies with tumors of mice. Cancer Treat Rep, 631: 1459–1473
- Moynihan T, Hansen R, Anderson T. Continuous 5 fluorouracil infusion in advanced gastric carcinoma. Am J Clin Oncol 1988; 11: 461–464
- Cantrell JE, Jr, Hart RD, Taylor RF, Harvey JH, Jr. Pilot trial of prolonged continuous infusiohn 5-fluorouracil and weekly cisplatin in advanced colorectal cancer. Cancer Treat Rep 1987; 71: 615–618
- Ahlgren J, Gray R, Rothschild N, Richardson C. Phase II study of continuous infusion 5-fluorouracil (CI 5-FU) plus weekly cisplatin (DDP) as second line therapy for advanced measured colorectal adenocarcinoma. Proc Am Soc Clin Oncol 1987; 6: 83
- Cohn J, Tester W, Desai, et al. Continuous infusion (CI) 5-FU and weekly low dose cisplatin (DDP) in metastatic (M) gastrointestinal (GI) Malignancies. Proc Am Soc Clin Oncol 1988; 7: 115
- Burton GV, Grant JP, Bedrosian C, Cox E. Cisplatin (CDDP) and continuous infusion 5-FU chemotherapy in metastatic colon cancer. Proc Am Soc Clin Oncol 1987; 6: 85
- Hansen R, Quebbeman E, Beatty P, et al. Continuous 5-fluorouracil (5-FU) infusion plus pulse cis-platin (DDP)/mitomycin C (MTC) in advanced colorectal cancer. Proc Am Soc Clin Oncol 1988; 7: 112
- Cazap EL, Gisselbrecht C, Smith FP, et al. Phase II trials of 5-FU, doxorubicin and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach. Cancer Treat Rep 1986; 70: 781–783
- Moertel CG, Rubin J, O'Connell MJ, et al. A Phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinoma. J Clin Oncol 1986; 4: 1053–1057